Alberto Zaniboni

InstitutionMedical Oncology Unit
AddressBrescia
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in March 2021
    All Publications
    Bar chart showing 156 publications over 28 distinct years, with a maximum of 16 publications in 2015 and 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Petrelli F, Cherri S, Ghidini M, Perego G, Ghidini A, Zaniboni A. Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis. World J Methodol. 2021 May 20; 11(3):95-109. PMID: 34026583.
      Citations:    
    2. Di Cosimo S, Tagliaferri B, Generali D, Giudici F, Agustoni F, Bernardo A, Borgonovo K, Farina G, Luchena G, Luciani A, Nolè F, Palmeri L, Pietrantonio F, Poggi G, Zucali PA, Balletti E, Catania G, Bernocchi O, D'Antonio F, Giordano M, Grossi F, Lasagna A, La Verde N, Manzoni M, Montagna B, Olgiati A, Raimondi A, Rampinelli I, Verri E, Zaniboni A, Di Maio M, Beretta G, Danova M. Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study. Cancers (Basel). 2021 Mar 16; 13(6). PMID: 33809465.
      Citations:    
    3. Cherri S, Noventa S, Fanelli M, Calandra G, Prochilo T, Bnà C, Savelli G, Zaniboni A. Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era. Cancers (Basel). 2021 Mar 02; 13(5). PMID: 33801385.
      Citations:    
    4. Gamba P, Zaniboni A. [Smell and taste in CoViD-19 patients: the forgotten sense.] Recenti Prog Med. 2020 10; 111(10):614-618. PMID: 33078012.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Cherri S, Lemmers DHL, Noventa S, Abu Hilal M, Zaniboni A. Outcome of oncological patients admitted with COVID-19: experience of a hospital center in northern Italy. Ther Adv Med Oncol. 2020; 12:1758835920962370. PMID: 33062065.
      Citations: 1     
    6. Zaniboni A, Ghidini M, Grossi F, Indini A, Trevisan F, Iaculli A, Dottorini L, Moleri G, Russo A, Vavassori I, Brevi A, Rausa E, Boni L, Dondossola D, Valeri N, Ghidini A, Tomasello G, Petrelli F. A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic. Cancers (Basel). 2020 Aug 29; 12(9). PMID: 32872421.
      Citations: 5     
    7. Savelli G, Bonacina M, Rizzo A, Zaniboni A. Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with 18F-Fluorocholine PET/CT? Med Hypotheses. 2020 Nov; 144:109885. PMID: 32540605.
      Citations: 6     Fields:    Translation:HumansCells
    8. Cherri S, Noventa S, Zaniboni A. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? Med Hypotheses. 2020 Aug; 141:109758. PMID: 32387757.
      Citations:    Fields:    Translation:Humans